• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】15618

【品名】2-Oxoacetic acid; Glyoxylic Acid

【CA登记号】298-12-4

【 分 子 式 】C2H2O3

【 分 子 量 】74.03608

【元素组成】C 32.45% H 2.72% O 64.83%

与该中间体有关的原料药合成路线共 30 条

合成路线1

该中间体在本合成路线中的序号:(IX)

The cyclization of trifluoroacetylmethylpyridinium bromide (I) with 3-(4-trifluoromethylbenzoyl)acrylic acid (II) by means of ammonium acetate in refluxing methanol gives 2-trifluoromethyl-6-(4-trifluoromethylphenyl)isonicotinic acid (III), which by condensation with 2-bromopyridine (IV) by means of butyllithium in ethyl ether yields 2-trifluoromethyl-6-(4-trifluoromethylphenyl)4-pyridyl-2'-pyridyl ketone (V). Finally, this compound is reduced with H2 over Pt in aqueous concentrated HCl. The starting products are prepared as follows: 1) The acrylic acid (II) is obtained by condensation of maleic anhydride (VI) with 4-trifluoromethylphenylmagnesium bromide (VII) by means of ZnCl2 in refluxing ethyl ether. An alternative method is the condensation of 4-trifluoromethylacetophenone (VIII) with glyoxylic acid (IX) by means of triethylamine at 135 C. 2) The pyridinium salt (I) is prepared by bromination of 1,1,1-trifluoroacetone (X) giving 1,1,1-trifluoro-3-bromoacetone (XI), which is then condensed with pyridine.

1 La Montagne, M.P.; et al.; Antimalarials. 6. Synthesis, antimalarial activity and configurations of rracemic alpha-(2-piperidyl)-4-pyridinemethanols. J Med Chem 1974, 17, 5, 219-523.
2 Ash, A.B.; et al. (Department of the Army); 2-Substituted phenyl-6-trifluoromethyl-4-pyridylcarbinolamines. US 3940404 .
3 Ash, A.B.; et al. (Department of the Army); 2-Aryl-6-trifluoromethyl-4-pyridylcarbinolamine antimalarials. US 3953463 .
4 Ash, A.B.; et al. (Department of the Army); 2-Aryl-6-trifluoromethyl-4-pyridylcarbinolamine antimalarials. US 3886167 .
5 Castaner, J.; Roberts, P.J.; WR-180,409. Drugs Fut 1978, 3, 9, 694.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 39908 1-(3,3,3-trifluoro-2-oxopropyl)pyridinium bromide C8H7BrF3NO 详情 详情
(II) 39906 (E)-4-oxo-4-[4-(trifluoromethyl)phenyl]-2-butenoic acid C11H7F3O3 详情 详情
(III) 39910 2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]isonicotinic acid C14H7F6NO2 详情 详情
(IV) 29052 2-Bromopyridine;α-bromopyridine;α-bromoazine 109-04-6 C5H4BrN 详情 详情
(V) 39911 2-pyridinyl[2-(trifluoromethyl)-6-[4-(trifluoromethyl)phenyl]-4-pyridinyl]methanone C19H10F6N2O 详情 详情
(VI) 11182 2,5-Furandione; Maleic anhydride 108-31-6 C4H2O3 详情 详情
(VII) 39311 bromo[4-(trifluoromethyl)phenyl]magnesium C7H4BrF3Mg 详情 详情
(VIII) 39907 1-[4-(trifluoromethyl)phenyl]-1-ethanone 709-63-7 C9H7F3O 详情 详情
(IX) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(X) 35449 1,1,1-trifluoroacetone 421-50-1 C3H3F3O 详情 详情
(XI) 39909 3-bromo-1,1,1-trifluoroacetone 431-35-6 C3H2BrF3O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The reaction of N-(2-oxo-2-phenylethyl)acetamide (I) with glyoxylic acid (II) by means of NaHCO3 in water gives threo-(2RS)-3-acetylamino-2-hydroxy-4-oxo-4-phenylbutanoic acid (III), which is reduced with H2 over Pd/C in acetic acid yielding threo-(2RS)-3-acetylamino-2-hydroxy-4-phenylbutanoic acid (IV). The treatment of (IV) with (S)-1-phenylethylamine followed by a fractionated crystallization affords (2S,3R)-3-acetyl-amino-2-hydroxy-4-phenylbutanoic acid (IV), which is hydrolyzed with HCl in refluxing water to afford (2R,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid (V). The protection of (V) with benzyl S-4,6-dimethylpyrimidin-2-ylthiolcarbonate (VI) by means of triethylamine in dioxane - water gives (2S,3R)-3-benzyloxycarbonylamino-2-hydroxy-4-phenylbutanoic acid (VII), which is condensed whh benzyl (S)-leucinate (VIII) by means of di-cyclohexylcarbodiimide and p-toluenesulfonic acid yielding benzyl (2S,3R)-3-benzyloxycarbonylamino-2-hydroxy-4-phenylbutanoyl-(S)-leucinate (IX). Finally, this compound is deprotected by hydrogenation with H2 over Pd/C in acetic acid.

1 Umezawa, H.; Aoyagi, T.; Shirai, T.; Nishizawa, R.; Suzuki, M.; Saino, T. (Nippon Kayaku Co., Ltd.); Process for producing threo-3-amino-2-hydroxybutanoyl-aminoacetic acids, as well as novel intermediated therefor and process for producing them. DE 2947140; ES 486572; FR 2442227; GB 2090595; US 4281180 .
2 Castaner, J.; Blancafort, P.; Serradell, M.N.; Bestatin. Drugs Fut 1981, 6, 10, 604.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14601 N-(2-oxo-2-phenylethyl)acetamide C10H11NO2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 32263 (2S,3S)-3-(acetamido)-2-hydroxy-4-oxo-4-phenylbutyric acid; threo-(2RS)-3-acetamido-2-hydroxy-4-oxo-4-phenylbutyric acid C12H13NO5 详情 详情
(IV) 32264 (2S,3R)-3-(acetamido)-2-hydroxy-4-phenylbutyric acid; threo-(2RS)-3-acetamido-2-hydroxy-4-phenylbutyric acid C12H15NO4 详情 详情
(V) 32265 (2S,3R)-3-amino-2-hydroxy-4-phenylbutyric acid; (2R,3S)-3-amino-2-hydroxy-4-phenylbutyric acid 62023-63-6 C10H13NO3 详情 详情
(VI) 32266 O-benzyl S-(4,6-dimethyl-2-pyrimidinyl) carbonothioate; benzyl S-4,6-dimethylpyrimidin-2-ylthiolcarbonate C14H14N2O2S 详情 详情
(VII) 32267 (2S,3R)-3-benzyIoxycarbonyIamino-2-hydroxy-4-phenylbutyric acid; (2S,3R)-3-[[(benzyloxy)carbonyl]amino]-2-hydroxy-4-phenylbutyric acid C18H19NO5 详情 详情
(VIII) 22252 Benzyl (2S)-2-amino-4-methylpentanoate; Benzyl (S)-leucinate C13H19NO2 详情 详情
(IX) 32268 benzyl (2S)-2-[((2S,3R)-3-[[(benzyloxy)carbonyl]amino]-2-hydroxy-4-phenylbutanoyl)amino]-4-methylpentanoate; benzyl (2S,3R)-3-Benzyloxycarbonylamino-2-hydroxy-4-phenylbutanoyI-(S)-Ieucinate C31H36N2O6 详情 详情

合成路线3

该中间体在本合成路线中的序号:(X)

This compound can be prepared by two related ways: 1) The condensation of methoxyacetaldehyde (I) with isopropylamine (II) gives methoxyacetaldehyde isopropylimine (III), which is treated with 4-benzyloxyindole (IV) in acetic acid yielding 4-benzyloxy-3-(1-isopropylamino-2-ethoxyethyl)indole (V). The reaction of (V) with ethyl nitroacetate (VI) in hot toluene affords ethyl 3-(4-benzyloxyindol-3-yl)-2-nitro-5-oxahexanoate (VII), which is reduced with H2 over Raney-Ni in ethanol giving ethyl 3-(4-benzyloxyindol-3-yl)-2-amino-5-oxahexanoate (VIII). Finally, this compound is cyclized with paraformaldehyde (IX) in refluxing benzene. 2) Compound (VIII) can also be cyclized with glyoxylic acid (X) yielding a mixture of the tetrahydrocarboline (XI) and the dihydrocarboline (XII), which, without separation, are decarboxylated and dehydrogenated with sulfur at 140 C.

1 Neef, G.; Schmiechen, R.; Huth, A.; Eder, U.; Rathz, D.; Seidelmann, D.; Synthesis of 4-sibstituted beta-carbolines. Heterocycles 1983, 20, 7, 1295-1313.
2 Neef, G.; Eder, U.; Schmiechen, R.; Huth, A.; Rathz, D.; Seidelmonn, D.; Kehr, W.; Palenschat, D.; Braestrup, C.T.; et al. (Schering AG); Pharmacologically active 3-substituted beta-carbolines. DD 161210; EP 0054507; ES 8301984; US 4435403; US 4596808 .
3 Castaner, J.; Serradell, M.N.; ZK-91296. Drugs Fut 1984, 9, 10, 761.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 34354 2-methoxyacetaldehyde 10312-83-1 C3H6O2 详情 详情
(II) 23933 2-Propanamine; Isopropylamine 75-31-0 C3H9N 详情 详情
(III) 34355 N-[(E)-2-methoxyethylidene]-2-propanamine; N-isopropyl-N-[(E)-2-methoxyethylidene]amine C6H13NO 详情 详情
(IV) 31535 4-Benzyloxyindole; 4-(benzyloxy)-1H-indole; benzyl 1H-indol-4-yl ether 20289-26-3 C15H13NO 详情 详情
(V) 34356 N-[1-[4-(benzyloxy)-1H-indol-3-yl]-2-methoxyethyl]-2-propanamine; N-[1-[4-(benzyloxy)-1H-indol-3-yl]-2-methoxyethyl]-N-isopropylamine C21H26N2O2 详情 详情
(VI) 15050 ethyl 2-nitroacetate; Acetic acid, nitro-, ethyl ester 626-35-7 C4H7NO4 详情 详情
(VII) 34357 ethyl 3-[4-(benzyloxy)-1H-indol-3-yl]-4-methoxy-2-nitrobutanoate C22H24N2O6 详情 详情
(VIII) 34358 ethyl 2-amino-3-[4-(benzyloxy)-1H-indol-3-yl]-4-methoxybutanoate C22H26N2O4 详情 详情
(X) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XI) 34359 5-(benzyloxy)-3-(ethoxycarbonyl)-4-(methoxymethyl)-2,3,4,9-tetrahydro-1H-beta-carboline-1-carboxylic acid C24H26N2O6 详情 详情
(XII) 34360 5-(benzyloxy)-3-(ethoxycarbonyl)-4-(methoxymethyl)-2,4a,9,9a-tetrahydro-1H-beta-carboline-1-carboxylic acid C24H26N2O6 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

The reaction of 3-ethoxycarbonyl-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido [1,2-a]pyrimidine (I) with glyoxilic acid (II) in ethanolic HCl gives 3-ethoxycarbonyl-6-methyl-4-oxo-9-carboxymethylen-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine (IIIa-b), which is reduced with H2 over Pd/C in ethanol.

1 Hermecz, I.; et al.; US 4123533 .
2 Paton, D.M.; Castaner, J.; CHINOIN-123. Drugs Fut 1979, 4, 11, 788.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IIIa) 39529 (Z)-2-[3-(ethoxycarbonyl)-6-methyl-4-oxo-7,8-dihydro-4H-pyrido[1,2-a]pyrimidin-9(6H)-ylidene]acetic acid C14H16N2O5 详情 详情
(IIIb) 39530 (E)-2-[3-(ethoxycarbonyl)-6-methyl-4-oxo-7,8-dihydro-4H-pyrido[1,2-a]pyrimidin-9(6H)-ylidene]acetic acid C14H16N2O5 详情 详情
(I) 36161 ethyl 6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylate C12H16N2O3 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(II)

The condensation of 2-pyrrolidinone (I) with 2-oxoacetic acid (II) in ethyl ether gives 2-hydroxy-2-(2-oxopyrrolidin-1-yl)acetic acid (III), which is fully methylated with methanol and conc. sulfuric acid to yield 2-methoxy-2-(2-oxopyrrolidin-1-yl)acetic acid methyl ester (IV). The reaction of (IV) with PCl3 in hot toluene affords 2-chloro-2-(2-oxopyrrolidin-1-yl)acetic acid methyl ester (V), which is condensed with triethyl phosphite (VI), also in hot toluene, to provide the dimethyl phosphonate (VII). The condensation of (VII) with acetaldehyde (VIII) in THF by means of tetramethylguanidine gives 2-(2-oxopyrrolidin-1-yl)-2-butenoic acid methyl ester (IX), which is reduced with H2 and a chiral Rhodium catalyst in THF to yield 2(S)-(2-oxopyrrolidin-1-yl)butyric acid methyl ester (X). Finally, this ester is treated with ammonia in methanol to afford the target chiral amide.

1 Boaz, N.W.; Debenham, S.D.; Highly enantiomerically pure lactam-substd. propanoic acid derivs. and methods of making and using same. WO 0226705 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 27397 2-Pyrrolidinone 616-45-5 C4H7NO 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 61966 2-hydroxy-2-(2-oxo-1-pyrrolidinyl)acetic acid C6H9NO4 详情 详情
(IV) 61967 methyl 2-methoxy-2-(2-oxo-1-pyrrolidinyl)acetate C8H13NO4 详情 详情
(V) 61968 methyl 2-chloro-2-(2-oxo-1-pyrrolidinyl)acetate C7H10ClNO3 详情 详情
(VI) 12642 Trimethyl phosphite 121-45-9 C3H9O3P 详情 详情
(VII) 61969 methyl 2-(dimethoxyphosphoryl)-2-(2-oxo-1-pyrrolidinyl)acetate C9H16NO6P 详情 详情
(VIII) 11974 Acetaldehyde 75-07-0 C2H4O 详情 详情
(IX) 61970 methyl (E)-2-(2-oxo-1-pyrrolidinyl)-2-butenoate C9H13NO3 详情 详情
(X) 61971 methyl (2S)-2-(2-oxo-1-pyrrolidinyl)butanoate C9H15NO3 详情 详情

合成路线6

该中间体在本合成路线中的序号:(I)

The cyclization of glyoxylic acid (I) with cyclopentadiene (II) gives the racemic hydroxylactone (III), which is acylated with Ac2O to yield acetoxy compound (rac)-(IV). The enzymatic optical resolution of (rac)-(IV) by means of Pseudomonas fluorescens affords the chiral hydroxylactone (-)-(V), which is reduced with LiAlH4 in refluxing THF to provide the lactol (VI). The oxidation of (VI) with NaIO4 in ethyl ether/water gives the chiral carbaldehyde (VII), which is reduced with NaBH4 in ethanol to afford the diol (VIII). The reaction of (VIII) with triphosgene by means of TEA in dichloromethane affords the cyclic carbonate (IX), which is condensed with chloropurine (X) by means of Pd(PPh3)4 in DMSO/THF to provide the adduct (XI). Finally, this compound is hydrolyzed with NaOH to afford the target (-)-carbovir.

1 Yu, J.; Olivo, H.F.; Practical enantiodivergent syntheses of both enantiomers of carbovir, 1592U89 and six-membered ring analogues. J Chem Soc - Perkins Trans I 1998, 3, 3, 391-2.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(II) 11183 1,3-Cyclopentadiene C5H6 详情 详情
(III) 55545 (3S,3aR,6aR)-3-hydroxy-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one C7H8O3 详情 详情
(IV) 17679 (3S,3aR,6aR)-2-oxo-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-3-yl acetate C9H10O4 详情 详情
(V) 17678 (3S,3aR,6aR)-3-hydroxy-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one C7H8O3 详情 详情
(VI) 55544 (3S,3aR,6aR)-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2,3-diol C7H10O3 详情 详情
(VII) 17682 (1S,2R)-2-hydroxy-3-cyclopentene-1-carbaldehyde C6H8O2 详情 详情
(VIII) 17671 (1R,5R)-5-(hydroxymethyl)-2-cyclopenten-1-ol C6H10O2 详情 详情
(IX) 17673 (4aR,7aR)-4,4a,5,7a-tetrahydrocyclopenta[d][1,3]dioxin-2-one C7H8O3 详情 详情
(X) 11644 6-Chloro-9H-purin-2-amine; 6-Chloro-9H-purin-2-ylamine; 2-Amino-6-chloropurine 10310-21-1 C5H4ClN5 详情 详情
(XI) 17650 [(1S,4R)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopenten-1-yl]methanol C11H12ClN5O 详情 详情

合成路线7

该中间体在本合成路线中的序号:(II)

Aldol condensation between 1-indanone (I) and glyoxylic acid (II) in the presence of H2SO4 afforded keto acid (III). Catalytic hydrogenation of (III) over Pd/C furnished 2-indanylacetic acid (IV).

1 Arai, H.; Niwa, S.; Nishioka, H.; Yamanaka, T.; Torizuka, M.; Yoshinaga, K.; Kobayashi, N.; Ikeda, Y.; Tanaka, Y.; New potent prolyl endopeptidase inhibitors: Synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues. J Med Chem 1994, 37, 13, 2071.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 23857 1-indanone 83-33-0 C9H8O 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 55611 2-(1-oxo-1,3-dihydro-2H-inden-2-ylidene)acetic acid C11H8O3 详情 详情
(IV) 21721 2-(2,3-dihydro-1H-inden-2-yl)acetic acid 37868-26-1 C11H12O2 详情 详情

合成路线8

该中间体在本合成路线中的序号:(V)

The Grignard condensation of phenylethynylmagnesium bromide with acetic anhydride in THF gives 4-phenyl-3-butyn-2-one (II), which is cyclized with 1-aminopyridinium iodide (III) by means of KOH in dichloromethane yielding the pyrazolopyridine (IV). The reaction of (IV) with 2-oxoacetic acid (V) by means of acetic acid in dimethoxyethane (DME) affords the butyric acid derivative (VI), which is cyclized with hydrazine in hot DMA to give the pyridazinone (VII). The condensation of (VII) with 4-bromobutyric acid ethyl ester (VIII) by means of benzyltriethylammonium chloride in hot DME/methanol provides the butyric ester intermediate (IX), which is finally hydrolyzed with NaOH.

1 Zanka, A.; et al.; Pilot-scale synthesis of a novel non-xanthine adenosine A1 receptor antagonist. 1,3-dipolar cycloaddition of pyridine N-immine to an acetylene. Org Process Res Dev 1998, 2, 5, 320.
2 Zanka, A.; Efficient large-scale synthesis of 4-phenyl-3-butyn-2-one, a key intermediate for a novel potent adenosine antagonist. Org Process Res Dev 1998, 2, 1, 60.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 32758 bromo(2-phenylethynyl)magnesium;phenylacetylenyl magnesium bromide;(phenylethynyl)magnesium bromide C8H5BrMg 详情 详情
(II) 32759 4-phenyl-3-butyn-2-one 1817-57-8 C10H8O 详情 详情
(III) 32760 1-aminopyridinium iodide C5H7IN2 详情 详情
(IV) 32760 1-aminopyridinium iodide C5H7IN2 详情 详情
(V) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(VI) 32761 2-hydroxy-4-oxo-4-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)butyric acid C17H14N2O4 详情 详情
(VII) 17984 6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone C17H12N4O 详情 详情
(VIII) 11263 ethyl 4-bromobutanoate; Ethyl 4-bromobutyrate 2969-81-5 C6H11BrO2 详情 详情
(IX) 32762 ethyl 4-[6-oxo-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-1(6H)-pyridazinyl]butanoate C23H22N4O3 详情 详情

合成路线9

该中间体在本合成路线中的序号:(XXXV)

5) The water promoted condensation of glyoxylic acid (XXXV) with cyclopentadiene (XXXVI) gives the racemic cis-hydroxylactone (XXXVII), which is acetylated with acetic anhydride to the acetate (XXXVIII). The selective enzymatic hydrolysis of (XXXVIII) with Pseudomonas fluorescens lipase yields the pre (-)-enantiomer (XXXIX), which is reduced with LiAlH4 in refluxing THF, affording triol (XL). The oxidation of the vicinal glycol of (XL) with NaIO4 in ethyl ether/water yields the hydroxyaldehyde (XLI), which is reduced with NaBH4 in ethanol to give the key intermediate 5(R)-(hydroxymethyl)-2-cyclopenten-1(R)-ol (XXX). This compound, by reaction with triphosgene and triethylamine in dichloromethane, results in the cyclic carbonate intermediate (XXXII), already reported.

1 Yu, J.; Olivo, H.F.; Practical enantiodivergent syntheses of both enantiomers of carbovir, 1592U89 and six-membered ring analogues. J Chem Soc - Perkins Trans I 1998, 3, 3, 391-2.
2 Graul, A.; Castaner, J.; Leeson, P.A.; Abacavir Sulfate. Drugs Fut 1998, 23, 11, 1155-1167.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXX) 17671 (1R,5R)-5-(hydroxymethyl)-2-cyclopenten-1-ol C6H10O2 详情 详情
(XXXII) 17673 (4aR,7aR)-4,4a,5,7a-tetrahydrocyclopenta[d][1,3]dioxin-2-one C7H8O3 详情 详情
(XXXV) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XXXVI) 11183 1,3-Cyclopentadiene C5H6 详情 详情
(XXXVII) 63844 (rac)-(3R*,3aS*,6aS*)-3-hydroxy-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one C7H8O3 详情 详情
(XXXVIII) 17679 (3S,3aR,6aR)-2-oxo-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-3-yl acetate C9H10O4 详情 详情
(XXXIX) 17678 (3S,3aR,6aR)-3-hydroxy-3,3a,4,6a-tetrahydro-2H-cyclopenta[b]furan-2-one C7H8O3 详情 详情
(XL) 17681 (1S)-1-[(1S,2R)-2-hydroxy-3-cyclopenten-1-yl]-1,2-ethanediol C7H12O3 详情 详情
(XLI) 17682 (1S,2R)-2-hydroxy-3-cyclopentene-1-carbaldehyde C6H8O2 详情 详情

合成路线10

该中间体在本合成路线中的序号:(XIV)

The second general approach to synthesis of lamivudine does not involve intermediacy of the racemic nucleoside. A variety of routes are available for preparing chiral oxathiolane intermediates which may be coupled to the cytosine base under appropriate conditions where the chirality of the oxathiolane is maintained. Various natural carbohydrate precursors have utility in the synthesis of lamivudine; for example, a synthesis from L-gulose has recently been reported. (+)-Thiolactic acid (XI) has served as a starting material for chiral oxathiolane (XII), which is coupled to silylated cytosine in the presence of TMS-iodide to afford (XIII). Separation of the pure beta-anomer and deprotection affords lamivudine. Alternatively, racemic acid (XV) may be prepared from glyoxylic acid (XIV) and resolution using a suitable chiral base such as norephedrine would afford the chiral acid (XVI), which may be esterified prior to coupling with cytosine to give (XVII) followed by final reduction to lamivudine.

1 Jones, M.F.; Siddiqui, A.; Payne, J.J.; Tse, H.L.A.; Humber, D.-C.; Ramsey, M.V.J.; Zacharie, B.; Jin, H.; Evans, C.A.; Expeditious preparation of (-)-2'-deoxy-3'-thiacytidine (3TC). Tetrahedron Lett 1992, 33, 32, 4625-8.
2 Storer, R.; Wilcox, P.; Daniel, M.; Collis, P.; Cameron, J.M.; Lamivudine. Drugs Fut 1993, 18, 4, 319.
3 Kim, H.O.; Chu, C.K.; Beach, J.W.; Schinazi, R.F.; Doong, S.-L.; Alves, A.J.; Pohl, D.; Chang, C.-N.; Jeong, L.S.; Cheng, Y.-C.; Synthesis of enantiomerically pure (2'R'5'S)-(-)-1-[2-(hydroxymethyl)oxathiolan-5yl]cytosine as a potential antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV). J Org Chem 1992, 57, 8, 2217-9.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
  64669 (2S,5S)-2-[(benzoyloxy)methyl]-1,3-oxathiolane-5-carboxylic acid C12H12O5S 详情 详情
  64670 (2R,5S)-2-[(benzoyloxy)methyl]-1,3-oxathiolane-5-carboxylic acid C12H12O5S 详情 详情
  64671 methyl (2R,5R)-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate C7H10O5S 详情 详情
(I) 15606 2,2-dimethoxy-1-ethanethiol; 2,2-dimethoxyethylhydrosulfide C4H10O2S 详情 详情
(XI) 15615 (2S)-2-hydroxy-3-sulfanylpropionic acid C3H6O3S 详情 详情
(XII) 15616 [(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl benzoate C13H14O5S 详情 详情
(XIII) 15617 [(2R)-5-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl benzoate C15H15N3O4S 详情 详情
(XIV) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XV) 15619 5-(acetoxy)-1,3-oxathiolane-2-carboxylic acid C6H8O5S 详情 详情
(XVI) 15620 (2R,5R)-5-(acetoxy)-1,3-oxathiolane-2-carboxylic acid 147027-05-2 C6H8O5S 详情 详情
(XVII) 15621 methyl (2R,5S)-5-[4-amino-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolane-2-carboxylate C9H11N3O4S 详情 详情

合成路线11

该中间体在本合成路线中的序号:(A)

This compound has been obtained by two related ways: 1) The sulfonation of 3,5-dichloroaniline (I) with chlorosulfonic acid gives 2-amino-4,6-dichlorobenzenesulfonyl chloride (II), which is condensed with 3-bromobenzylamine (III) by means of TEA yielding the corresponding sulfonamide (IV). The cyclization of (IV) with glyoxylic acid (A) in ethanol/sulfuric acid affords the esterified benzothiadiazine-3-carboxylate (V), which is finally hydrolyzed with aqueous NaOH. 2) The reaction of sulfonyl chloride (II) with liquid ammonia gives the corresponding sulfonamide (VI), which is cyclized with glyoxylic acid (A) as before yielding the benzothiadiazine (VII). Finally the alkylation of (VII) with 3-bromobenzyl bromide (VIII) by means of NaH affords the already reported benzothiadiazine-3-carboxylate (V). 3) The enantiomers of the title compound have been obtained in optically pure form by preparative liquid chromatography on a Pirkle-type chiral phase column.

1 Shot, J.H.; Biermacher, U.; Synthesis of potential diuretic agents. II. Dichloro-derivatives of 1,2,4-benzothiadiazine-1,1-dioxide. J Am Chem Soc 1960, 2, 1135-38.
2 Mignani, S.; et al.; 2H-3,4-Dihydro-1,2,4-benzothiadiazine-1, 1-dioxide-3-carboxylic acid derivatives, a novel family of glycine antagonists of the NMDA receptor channel complex. Drugs Fut 1995, 20, 11, 1133.
3 Jimonet, P.; et al.; Synthesis and SAR of 2H-1,2,4-benzothiadiazine-1, 1-dioxide-3-carboxylic acid derivatives as novel potent glycine antagonists of the NMDA receptor-channel complex. Bioorg Med Chem Lett 1994, 4, 23, 2735.
4 Boireau, A.; Malgouris, C.; Burgevin, M.C.; et al.; Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. Eur J Pharmacol 1996, 300, 3, 237.
5 Doble, A.; Boireau, A.; et al.; RPR 104632, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor-channel complex. Can J Physiol Pharmacol 1994, 72, Suppl. 1, 333.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(I) 26542 3,5-dichloroaniline 626-43-7 C6H5Cl2N 详情 详情
(II) 41179 2-amino-4,6-dichlorobenzenesulfonyl chloride C6H4Cl3NO2S 详情 详情
(III) 41180 (3-bromophenyl)methanamine; 3-bromobenzylamine C7H8BrN 详情 详情
(IV) 41181 2-amino-N-(3-bromobenzyl)-4,6-dichlorobenzenesulfonamide C13H11BrCl2N2O2S 详情 详情
(V) 41182 ethyl 2-(3-bromobenzyl)-6,8-dichloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda(6),2,4-benzothiadiazine-3-carboxylate C17H15BrCl2N2O4S 详情 详情
(VI) 41183 2-amino-4,6-dichlorobenzenesulfonamide C6H6Cl2N2O2S 详情 详情
(VII) 41184 ethyl 6,8-dichloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda(6),2,4-benzothiadiazine-3-carboxylate C10H10Cl2N2O4S 详情 详情
(VIII) 20466 1-bromo-3-(bromomethyl)benzene 823-78-9 C7H6Br2 详情 详情

合成路线12

该中间体在本合成路线中的序号:(II)

The cyclization of 4-chlorophenylene-1,2-diamine (I) with glyoxylic acid (II) in isopropanol gives a mixture of 7-chloroquinoxalin-2-ol (III) and 6-chloroquinoxalin-2-ol (IV), which, without isolation is treated with refluxing POCl3, and the resulting mixture of dichloro compounds is submitted to flash chromatography to obtain the desired 2,7-dichloroquinoxaline (V). The condensation of (V) with 2-(4-hydroxyphenoxy)propionic acid methyl ester (VI) by means of K2CO3 in refluxing acetone affords the ester precursor (VII), which is hydrolyzed with KOH in THF/water and acidified with HCl to provide the racemic 2-[4-(7-chloroquinoxalin-2-yloxy)phenoxy]propionic acid (VIII). Finally, this compound is converted into its sodium salt with NaOH in water.

1 Behrens, C.H.; Dusak, B.A.; Harrison, B.A.; Orwat, M.J. (Bristol-Myers Squibb Co.); (2-Quinoxalinyloxy)phenoxypropanoic acids and related derivs. as anticancer agents. WO 9413647 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 55570 2-Amino-5-chlorobenzamide; 3,4-Diaminochlorobenzene; 4-Chloro-1,2-diaminobenzene; 4-Chloro-1,2-phenylenediamine; 4-Chloro-o-phenylenediamine 95-83-0 C6H7ClN2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 56728 7-chloro-2-quinoxalinol C8H5ClN2O 详情 详情
(IV) 56729 6-chloro-2-quinoxalinol C8H5ClN2O 详情 详情
(V) 56725 2,7-dichloroquinoxaline 59489-31-5 C8H4Cl2N2 详情 详情
(VI) 56730 Methyl D-2-(4-hydroxyphenoxy)propionate 96562-58-2 C10H12O4 详情 详情
(VII) 56731 methyl 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propanoate C18H15ClN2O4 详情 详情
(VIII) 56732 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propanoic acid C17H13ClN2O4 详情 详情

合成路线13

该中间体在本合成路线中的序号:(XXIV)

The chiral piperidine (2S,4R)(VI) has been obtained as follows: The cyclization of 3-buten-1-ol (XXII) with (S)-1-phenylethylamine (XXIII) and glyoxylic acid (XXIV) by means of tosyl chloride in THF gives a mixture of the (2S,4R) and (2R,4S) lactones (XXV), which is resolved by fractional crystallyzation of their salts with the chiral camphorsulfonic acid (XXVI), followed by elimination of the acid with ammonia to afford (2S,4R)(XXVII). The reaction of lactone (XXVII) with isopropylmagnesium chloride and tert-butylamine in THF gives (2S,4R)-N-tert-butyl-4-hydroxy-1-(1(S)-phenylethyl)piperidine-2-carboxamide (XXVIII), which is debenzylated by hydrogenation and protected with tert-butoxycarbonyl anhydride yielding (2S,4R)-N-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxamide (2S,4R)(XI), which is finally condensed with 4-(chloromethyl)pyridine (XII) as before to obtain the chiral piperidine (2S,4R)(VI), already reported.

1 Beaulieu, P.L.; et al.; Practical, stereoselective synthesis of palinavir, a potent HIV protease inhibitor. J Org Chem 1997, 62, 11, 3440.
2 Gillard, J.; et al.; Preparation of (2S,4R)-4-hydroxypipecolic acid and derivatives. J Org Chem 1996, 61, 6, 2226.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VI) 19731 (2S,4R)-N-(tert-butyl)-4-(4-pyridinylmethoxy)-2-piperidinecarboxamide C16H25N3O2 详情 详情
(XI) 19736 tert-butyl (2S,4R)-2-[(tert-butylamino)carbonyl]-4-hydroxy-1-piperidinecarboxylate C15H28N2O4 详情 详情
(XII) 10844 4-(Chloromethyl)pyridine 10445-91-7 C6H6ClN 详情 详情
(XXII) 19743 3-buten-1-ol 627-27-0 C4H8O 详情 详情
(XXIII) 10039 (1R)-1-Phenylethylamine; (1R)-1-Phenyl-1-ethanamine.; L-alpha-Phenylethylamine 3886-69-9 C8H11N 详情 详情
(XXIV) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XXV) 19746 2-[(1S)-1-phenylethyl]-6-oxa-2-azabicyclo[3.2.1]octan-7-one C14H17NO2 详情 详情
(XXVI) 19747 (3-bromo-1,7-dimethyl-2-oxobicyclo[2.2.1]hept-7-yl)methanesulfonic acid C10H15BrO4S 详情 详情
(XXVII) 19748 (1S,5R)-2-[(1S)-1-phenylethyl]-6-oxa-2-azabicyclo[3.2.1]octan-7-one C14H17NO2 详情 详情
(XXVIII) 19749 (2S,4R)-N-(tert-butyl)-4-hydroxy-1-[(1S)-1-phenylethyl]-2-piperidinecarboxamide C18H28N2O2 详情 详情

合成路线14

该中间体在本合成路线中的序号:(VIII)

Dehydroxylation of compound (I) by hydrogenation over Pd/C in MeOH provides tetralinecarboxylic acid methyl ester (II), which is then reduced by means of LiAlH4 in THF to afford tetralinemethanol as a mixture of enantiomers (III). Separation of isomers in (III) is then achieved by first acylation of the alcohol with (-)-menthyl chloroformate (IV) in pyridine, followed by the separation of the two resulting diastereomers by recrystallization to give (-)-menthyl carbonate (V) and its subsequent hydrolysis with NaOH in THF/H2O to furnish compound (VI).

1 Tsubaki, K.; Hattori, K.; Tabuchi, S.; Okitsu, O.; Sakane, K.; Tanaka, H.; Taniguchi, K.; A novel pyridazinone derivative as a nonprostanoid PGI2 agonist. Bioorg Med Chem Lett 2000, 10, 24, 2787.
2 Taniguchi, K.; Nagano, M.; Hattori, K.; Tsubaki, K.; Okitsu, O.; Tabuchi, S. (Fujisawa Pharmaceutical Co., Ltd.); Naphthalene derivs. as prostaglandin I2 agonists. EP 0749424; JP 1997509958; US 5763489; WO 9524393 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 46774 methyl (1R,2S)-1-hydroxy-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenecarboxylate C13H16O4 详情 详情
(II) 46775 methyl (2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenecarboxylate C13H16O3 详情 详情
(III) 46776 (5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl)methanol C12H16O2 详情 详情
(IV) 46777 (1S,2R,4R)-2-[(chlorocarbonyl)oxy]-1-isopropyl-4-methylcyclohexane 14602-86-9 C11H19ClO2 详情 详情
(V) 46778 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl [(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]methyl carbonate C23H34O4 详情 详情
(VI) 46779 [(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]methanol C12H16O2 详情 详情
(VII) 46780 1,1-diphenylacetone 781-35-1 C15H14O 详情 详情
(VIII) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IX) 46781 2-hydroxy-4-oxo-5,5-diphenylpentanoic acid C17H16O4 详情 详情
(X) 46782 6-benzhydryl-1,6-dihydro-3(2H)-pyridazinone C17H16N2O 详情 详情
(XI) 46783 6-benzhydryl-2-[[(2S)-5-methoxy-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]-1,6-dihydro-3(2H)-pyridazinone C29H30N2O2 详情 详情
(XII) 46784 6-benzhydryl-2-[[(2S)-5-hydroxy-1,2,3,4-tetrahydro-2-naphthalenyl]methyl]-1,6-dihydro-3(2H)-pyridazinone C28H28N2O2 详情 详情
(XIII) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(XIV) 46785 ethyl 2-[((6S)-6-[[3-benzhydryl-6-oxo-3,6-dihydro-1(2H)-pyridazinyl]methyl]-5,6,7,8-tetrahydro-1-naphthalenyl)oxy]acetate C32H34N2O4 详情 详情

合成路线15

该中间体在本合成路线中的序号:(III)

Nitration of chromanone (I) with fuming HNO3 at -35 C afforded 6-nitro-4-chromanone (II). Subsequent aldol condensation of (II) with glyoxylic acid (III) in the presence of H2SO4 produced the alpha-beta-unsaturated acid (IV). Further hydrogenation of the nitro, keto, and olefin groups of (IV) with concomitant esterification produced the benzopyranylacetate (V). After protection of (V) as the N-Boc derivative (VI), optical resolution was achieved by preparative HPLC on a Chiralcel-OD column. The desired (S)-enantiomer (VI) was deprotected using ethanolic HCl to afford amine (VII), which was condensed with 4-cyanobenzoyl chloride (VIII) to give amide (IX). Treatment of (IX) with HCl-EtOH produced imidate (X), and subsequent treatment with morpholine (XI) furnished the target amidine, which was isolated as the hydrochloride salt.

1 Okumura, K.; Shimazaki, T.; Aoki, Y.; Yamashita, H.; Tanaka, E.; Banba, S.; Yazawa, K.; Kibayashi, K.; Banno, H.; New platelet fibrinogen receptor glycoprotein IIb-. J Med Chem 1998, 41, 21, 4036.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14461 2,3-Dihydro-4H-chromen-4-one; 4-Chromanone 491-37-2 C9H8O2 详情 详情
(II) 23176 6-nitro-2,3-dihydro-4H-chromen-4-one C9H7NO4 详情 详情
(III) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IV) 23178 2-[6-nitro-4-oxo-2H-chromen-3(4H)-ylidene]acetic acid C11H7NO6 详情 详情
(V) 23179 methyl 2-(6-amino-3,4-dihydro-2H-chromen-3-yl)acetate C12H15NO3 详情 详情
(VI) 23180 methyl 2-[(3S)-6-[(tert-butoxycarbonyl)amino]-3,4-dihydro-2H-chromen-3-yl]acetate C17H23NO5 详情 详情
(VII) 23181 ethyl 2-[(3S)-6-amino-3,4-dihydro-2H-chromen-3-yl]acetate C13H17NO3 详情 详情
(VIII) 19280 4-cyanobenzoyl chloride 6068-72-0 C8H4ClNO 详情 详情
(IX) 23183 ethyl 2-[(3S)-6-[(4-cyanobenzoyl)amino]-3,4-dihydro-2H-chromen-3-yl]acetate C21H20N2O4 详情 详情
(X) 23184 ethyl 2-[(3S)-6-([4-[ethoxy(imino)methyl]benzoyl]amino)-3,4-dihydro-2H-chromen-3-yl]acetate C23H26N2O5 详情 详情
(XI) 10388 Morpholine 110-91-8 C4H9NO 详情 详情

合成路线16

该中间体在本合成路线中的序号:(III)

Nitration of chromanone (I) with fuming HNO3 at -35 C afforded 6-nitro-4-chromanone (II). Subsequent aldol condensation of (II) with glyoxylic acid (III) in the presence of H2SO4 produced the alpha-beta-unsaturated acid (IV). Further hydrogenation of the nitro, keto, and olefin groups of (IV) with concomitant esterification produced the benzopyranylacetate (V). After protection of (V) as the N-Boc derivative (VI), optical resolution was achieved by preparative HPLC on a Chiralcel-OD column. The desired (S)-enantiomer (VI) was deprotected using ethanolic HCl to afford amine (VII), which was condensed with 4-cyanobenzoyl chloride (VIII) to give amide (IX). Treatment of (IX) with HCl-EtOH produced imidate (X), and subsequent treatment with morpholine (XI) furnished amidine (XII). Finally, basic hydrolysis of the ester function provided the target amidinoacid, which was isolated as the hydrochloride salt.

1 Okumura, K.; Shimazaki, T.; Aoki, Y.; Yamashita, H.; Tanaka, E.; Banba, S.; Yazawa, K.; Kibayashi, K.; Banno, H.; New platelet fibrinogen receptor glycoprotein IIb-. J Med Chem 1998, 41, 21, 4036.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 14461 2,3-Dihydro-4H-chromen-4-one; 4-Chromanone 491-37-2 C9H8O2 详情 详情
(II) 23176 6-nitro-2,3-dihydro-4H-chromen-4-one C9H7NO4 详情 详情
(III) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IV) 23178 2-[6-nitro-4-oxo-2H-chromen-3(4H)-ylidene]acetic acid C11H7NO6 详情 详情
(V) 23179 methyl 2-(6-amino-3,4-dihydro-2H-chromen-3-yl)acetate C12H15NO3 详情 详情
(VI) 23180 methyl 2-[(3S)-6-[(tert-butoxycarbonyl)amino]-3,4-dihydro-2H-chromen-3-yl]acetate C17H23NO5 详情 详情
(VII) 23181 ethyl 2-[(3S)-6-amino-3,4-dihydro-2H-chromen-3-yl]acetate C13H17NO3 详情 详情
(VIII) 19280 4-cyanobenzoyl chloride 6068-72-0 C8H4ClNO 详情 详情
(IX) 23183 ethyl 2-[(3S)-6-[(4-cyanobenzoyl)amino]-3,4-dihydro-2H-chromen-3-yl]acetate C21H20N2O4 详情 详情
(X) 23184 ethyl 2-[(3S)-6-([4-[ethoxy(imino)methyl]benzoyl]amino)-3,4-dihydro-2H-chromen-3-yl]acetate C23H26N2O5 详情 详情
(XI) 10388 Morpholine 110-91-8 C4H9NO 详情 详情
(XII) 23186 ethyl 2-[(3S)-6-([4-[imino(4-morpholinyl)methyl]benzoyl]amino)-3,4-dihydro-2H-chromen-3-yl]acetate C25H29N3O5 详情 详情

合成路线17

该中间体在本合成路线中的序号:(II)

The cyclization of 2-(3,5-dimethoxyphenyl)glyoxal monohydrate (I) with methyl glyoxylic acid (II) and ammonium acetate in acetonitrile gives the aryl imidazole (III), which is protected with dihydrofuran (IV) and Ts-OH, yielding compound (V). The regioselective lithiation of (V) with n-BuLi, followed by reaction with labeled 14CO2 provides the carboxylic acid (VI), which is esterified with MeI and CaO in DMSO to furnish the methyl ester (VII). The reduction of the ester group of (VII) with LiBH4 affords the carbinol (VIII), which is esterified with trichloroacetonitrile (IX) to provide the trichloroacetimidate (X).

1 Egan, M.A.M.; et al.; Carbon-14 labeling of a potential new immunoregulant agent. J Label Compd Radiopharm 2000, 43, 11, 1095.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22759 1-(3,5-dimethoxyphenyl)-2,2-dihydroxy-1-ethanone C10H12O5 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 42281 4-(3,5-dimethoxyphenyl)-1H-imidazole; 3-(1H-imidazol-4-yl)-5-methoxyphenyl methyl ether C11H12N2O2 详情 详情
(IV) 22766 2,3-dihydrofuran 1191-99-7 C4H6O 详情 详情
(V) 42282 4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazole; 3-methoxy-5-(1-tetrahydro-2-furanyl-1H-imidazol-4-yl)phenyl methyl ether C15H18N2O3 详情 详情
(VI) 42283 lithium 4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazole-2-carboxylate C16H17LiN2O5 详情 详情
(VI) 45345 lithium 4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazole-2-carboxylate C16H17LiN2O5 详情 详情
(VII) 22767 methyl 4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazole-2-carboxylate C17H20N2O5 详情 详情
(VII) 45346 methyl 4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazole-2-carboxylate C17H20N2O5 详情 详情
(VIII) 22768 [4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazol-2-yl]methanol C16H20N2O4 详情 详情
(VIII) 45347 [4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazol-2-yl]methanol C16H20N2O4 详情 详情
(IX) 42279 2,2,2-trichloroacetonitrile; Trichloromethylcyanide 545-06-2 C2Cl3N 详情 详情
(X) 22769 [4-(3,5-dimethoxyphenyl)-1-tetrahydro-2-furanyl-1H-imidazol-2-yl]methyl 2,2,2-trichloroethanimidoate C18H20Cl3N3O4 详情 详情

合成路线18

该中间体在本合成路线中的序号:(III)

This compound has been obtained by several related ways: 1.- The Sam and Thompson cyclization of 3-(2-thienyl)acrylic acid (I) gives the thienocyclopentanone (II), which is condensed with oxoacetic acid (III) yielding 2-(4-oxo-5,6-dihydro-4H-cyclopenteno[b]furan-5-ylidene)acetic acid (IV). The reduction of (IV) with Zn and acetic acid affords the corresponding saturated compound (V), which is condensed with 4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine (VI) by means of DCC and HOBt in dichloromethane to give the corresponding piperidide (VII). The protection of the ketonic group of (VII) with ethylene glycol and TsOH yields the ethylene ketal (VIII), which is reduced at the piperidide group with LiAlH4 in ethyl ether yielding the final intermediate (IX). Finally, this compound is treated with HCl to eliminate the ethylene ketal protecting group. 2.- The condensation of the thienocyclopentanone (II) with ethyl bromoacetate (X) by means of LDA gives the acetate (XI), which is hydrolyzed with KOH in ethanol affording the previously reported saturated acetic acid derivative (V). 3.- The condensation of acetate (XI) with piperidine (VI) by means of Me3Al gives also the previously reported piperidide (VII).

1 Negreira, J.; Cid, J.; Raviña, E.; et al.; Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical an. J Med Chem 1999, 42, 15, 2774.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(A) 11295 Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol 107-21-1 C2H6O2 详情 详情
(I) 31893 (Z)-3-(2-thienyl)-2-propenoic acid 15690-25-2 C7H6O2S 详情 详情
(II) 31894 5,6-dihydro-4H-cyclopenta[b]thiophen-4-one C7H6OS 详情 详情
(III) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IV) 31895 2-(4-oxo-4,6-dihydro-5H-cyclopenta[b]thiophen-5-ylidene)acetic acid C9H6O3S 详情 详情
(V) 31896 2-(4-oxo-5,6-dihydro-4H-cyclopenta[b]thiophen-5-yl)acetic acid C9H8O3S 详情 详情
(VI) 17910 6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole C12H13FN2O 详情 详情
(VII) 31897 5-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-2-oxoethyl]-5,6-dihydro-4H-cyclopenta[b]thiophen-4-one C21H19FN2O3S 详情 详情
(VIII) 31898 3-[4,4-(Ethylenedioxy)-5,6-dihydro-4H-cyclopeta[b]thiophen-5-yl]-1-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)-1-propanone C23H23FN2O4S 详情 详情
(IX) 31899 1-[2-[4,4-(Ethylenedioxy)-5,6-dihydro-4H-cyclopenta[b]thiophen-5-yl]ethyl]-4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine C23H25FN2O3S 详情 详情
(X) 16640 Ethyl 2-bromoacetate; Ethyl bromoacetate 105-36-2 C4H7BrO2 详情 详情
(XI) 31900 ethyl 2-(4-oxo-5,6-dihydro-4H-cyclopenta[b]thiophen-5-yl)acetate C11H12O3S 详情 详情

合成路线19

该中间体在本合成路线中的序号:(II)

Glyoxylic acid (II), generated in situ by oxidative cleavage of tartaric acid (I) with sodium periodate, was condensed with deoxyanisoin (III) to provide the aldol adduct (IV). Cyclization of hydroxyacid (IV) with hydrazine gave rise to the hydroxy dihydropyridazinone (V), which was further dehydrated to (VI) upon treatment with p-toluenesulfonic acid in refluxing benzene. Finally, alkylation of pyridazinone (VI) with 4-chlorocinnamyl chloride (VII) in the presence of potassium carbonate furnished the title compound.

1 Matsuda, T.; et al.; Synthesis and bioactivities of novel 5,6-bis(4-methoxyphenyl)-2H-pyridazin-3-one derivatives: Inhibitors of interleukin-1 beta (IL-1beta) production. Bioorg Med Chem Lett 2001, 11, 17, 2373.
2 Yoshizaki, H.; Habata, Y.; Kumai, N.; Kotaki, K.; Ohkuchi, M.; Ohgiya, T.; Yamazaki, Y.; Matsuda, T.; Kitamura, T.; Koshi, T.; Kyotani, Y.; Shigyo, H. (Kowa Co., Ltd.); Novel pyridazine derivs. and drugs containing the same as the active ingredient. EP 1043317; JP 1999152274; JP 2000198776; US 6348468; WO 9925697 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52118 Uvic Acid; Tartaric acid; Dihydroxysuccinic acid; 2,3-Dihydroxybutanedioic acid 133-37-9 C4H6O6 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 22991 1,2-bis(4-methoxyphenyl)-1-ethanone 120-44-5 C16H16O3 详情 详情
(IV) 52114 2-hydroxy-3,4-bis(4-methoxyphenyl)-4-oxobutyric acid C18H18O6 详情 详情
(V) 52115 4-hydroxy-5,6-bis(4-methoxyphenyl)-4,5-dihydro-3(2H)-pyridazinone C18H18N2O4 详情 详情
(VI) 52116 5,6-bis(4-methoxyphenyl)-3(2H)-pyridazinone C18H16N2O3 详情 详情
(VII) 52117 1-chloro-4-[(E)-3-chloro-1-propenyl]benzene C9H8Cl2 详情 详情

合成路线20

该中间体在本合成路线中的序号:(XXVI)

In an alternative route to morpholine (XVIII), bromination of 1,3-bis(trifluoromethyl)benzene (XX) by means of 1,3-dibromo-5,5-dimethylhydantoin (XXI) yielded bromide (XXII). The Grignard reagent prepared from aryl bromide (XXII) was acylated with acetic anhydride at -15 C to produce acetophenone (XXIII). Enantioselective reduction of ketone (XXIII) with ruthenium(II) chloride in the presence of (1S,2R)-cis-1-amino-2-indanol furnished the (R)-alcohol (XXIV). N-Benzyl ethanolamine (XXV) was condensed with glyoxylic acid (XXVI) to give the hydroxy oxazinone (XXVII). This was coupled with the chiral alcohol (XXIV) using trifluoroacetic anhydride and boron trifluoride etherate to afford the target (R,R)-adduct (XXVIII) as the main diastereoisomer. Addition of 4-fluorophenylmagnesium bromide (XXIX) to the lactam function of (XXVIII), followed by catalytic hydrogenation of the intermediate (XXX), provided the required disubstituted morpholine (XVIII).

1 Wang, J.; Crocker, L.; Cai, D. (Merck & Co., Inc.); Polymorphic form of a tachykinin receptor antagonist. WO 0132656 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XVIII) 18293 (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl (2R,3S)-3-(4-fluorophenyl)morpholinyl ether; (2R,3S)-2-([(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]oxy)-3-(4-fluorophenyl)morpholine 171482-05-6 C20H18F7NO2 详情 详情
(XX) 53293 1,3-Bis(trifluoromethyl)benzene; 1,3-Di(trifluoromethyl)benzene; alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-m-xylene; m-Xylene hexafluoride 402-31-3 C8H4F6 详情 详情
(XXI) 31277 1,3-dibromo-5,5-dimethyl-2,4-imidazolidinedione 77-48-5 C5H6Br2N2O2 详情 详情
(XXII) 53294 1,3-Bis(trifluoromethyl)-5-bromobenzene; 1-Bromo-3,5-bis(trifluoromethyl)benzene; 3,5-Bis(trifluoromethyl)bromobenzene 328-70-1 C8H3BrF6 详情 详情
(XXIII) 40778 1-[3,5-bis(trifluoromethyl)phenyl]-1-ethanone 30071-93-3 C10H6F6O 详情 详情
(XXIV) 53295 (1R)-1-[3,5-bis(trifluoromethyl)phenyl]-1-ethanol n/a C10H8F6O 详情 详情
(XXV) 53296 4-benzyl-2-hydroxy-3-morpholinone 287930-73-8 C11H13NO3 详情 详情
(XXVI) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XXVII) 25630 2-(benzylamino)-1-ethanol 104-63-2 C9H13NO 详情 详情
(XXVIII) 53297 (2R)-4-benzyl-2-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}oxy)-3-morpholinone n/a C21H19F6NO3 详情 详情
(XXIX) 13643 4-fluorophenyl magnesium bromide;Bromo(4-fluorophenyl)magnesium;bromo(p-fluorophenyl)Magnesium;p-Fluorophenylmagnesium bromide 352-13-6 C6H4BrFMg 详情 详情
(XXX) 53298 (2R)-4-benzyl-2-({(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}oxy)-3-(4-fluorophenyl)-3-morpholinol n/a C27H24F7NO3 详情 详情

合成路线21

该中间体在本合成路线中的序号:(II)

Reductive condensation of 1,4-butanediamine (I) with glyoxylic acid (II) affords 3,8-diazaoctanoic acid (III). Subsequent acylation of diamino acid (III) with 2,3-diacetoxybenzoyl chloride (IV) provides diamide (V). After activation of (V) as the corresponding mixed anhydride with either methyl or isobutyl chloroformate, condensation with ampicillin (VI) yields the title compound.

1 RF-2691A. Drug Data Rep 1995, 17, 9, 867.
2 Berg, A.; Heinisch, L.; Mollmann, U.; Wittmann, S.; Scherlitz-Hofmann, I.; Stoiber, T. (Grunenthal GmbH); Catecholate beta-lactam conjugates, method for producing the same and the use thereof. DE 10111160; WO 0270016 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 42070 1,4-butanediamine; 4-aminobutylamine 110-60-1 C4H12N2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 58505 2-[(4-aminobutyl)amino]acetic acid C6H14N2O2 详情 详情
(IV) 58506 2-(acetyloxy)-3-(chlorocarbonyl)phenyl acetate C11H9ClO5 详情 详情
(V) 58507 2-[[2,3-bis(acetyloxy)benzoyl](4-{[2,3-bis(acetyloxy)benzoyl]amino}butyl)amino]acetic acid C28H30N2O12 详情 详情
(VI) 31107 (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylethanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 69-53-4 C16H19N3O4S 详情 详情

合成路线22

该中间体在本合成路线中的序号:(II)

The condensation of 1-tetralone (I) with 2-oxoacetic acid (II) by means of KOH gives 2-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-ylidene)acetic acid (III), which is cyclized with hydrazine in hot butanol to yield the tricyclic pyridazinone (IV). The treatment of (IV) with hot POCl3 gives the chloropyridazine derivative (V), which is treated with hydrazine in boiling water to provide the hydrazino derivative (VI). The hydrogenation of (VI) with H2 over Ni in methanol gives the aminopyridazine derivative (VII), which is condensed with ethyl 11-bromoundecanoate (VIII) (prepared by esterification of the corresponding acid (IX) with Et-OH/HCl) in hot DMF to yield the adduct (X). The hydrolysis of (X) with HCl in hot HOAc affords the corresponding acid (XI), which is finally condensed with 1-(2-pyrimidinyl)piperazine (XII) by means of HOBt and EDC in DMF to provide the target amide.

1 Mirzoeva, S.; Zasadzki, M.; Sawkar, A.; et al.; Discovery of a 3-amino-6-phenyl-pyridazine derivative as a new synthetic antineuroinflammatory compound. J Med Chem 2002, 45, 3, 563.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 20720 3,4-dihydro-1(2H)-naphthalenone 529-34-0 C10H10O 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 56768 2-[1-oxo-3,4-dihydro-2(1H)-naphthalenylidene]acetic acid C12H10O3 详情 详情
(IV) 56769 5,6-dihydrobenzo[h]cinnolin-3(2H)-one C12H10N2O 详情 详情
(V) 56770 3-chloro-5,6-dihydrobenzo[h]cinnoline C12H9ClN2 详情 详情
(VI) 56771 3-hydrazino-5,6-dihydrobenzo[h]cinnoline C12H12N4 详情 详情
(VII) 56772 5,6-dihydrobenzo[h]cinnolin-3-ylamine; 5,6-dihydrobenzo[h]cinnolin-3-amine C12H11N3 详情 详情
(VIII) 56773 Ethyl omega-bromoundecanoate; Ethyl 11-bromoundecanoate 6271-23-4 C13H25BrO2 详情 详情
(IX) 56774 11-Bromoundecanoic acid 2834-05-1 C11H21BrO2 详情 详情
(X) 56775 ethyl 11-[3-imino-5,6-dihydrobenzo[h]cinnolin-2(3H)-yl]undecanoate C25H35N3O2 详情 详情
(XI) 56776 11-[3-imino-5,6-dihydrobenzo[h]cinnolin-2(3H)-yl]undecanoic acid C23H31N3O2 详情 详情
(XII) 11175 2-(1-Piperazinyl)pyrimidine; 2-Piperazinopyrimidine; N-(Pyrimidinyl)piperazine 20980-22-7 C8H12N4 详情 详情

合成路线23

该中间体在本合成路线中的序号:(III)

The reaction of 5(R)-(azidomethyl)-3-phenyloxazolidin-2-one (I) with Ac2O and MsOH gives the 4-acetylphenyl derivative (II), which is cyclized with glyoxylic acid (III) and hydrazine (IV) in hot acetic acid to yield the pyridazinone derivative (V). The reduction of the azido group of (V) by means of PPh3 in THF/water affords the aminomethyl compound (VI), which is finally condensed with ethyl dithioacetate (VII) by means of TEA in DMF to provide the target thioacetamide.

1 Luehr, G.W.; Wang, S.; Hackbarth, C.J.; Gomez, M.; Trias, J.; Patel, D.V.; Gordeev, M.F.; Novel antimicrobial pyridazine phenyloxazolidinones. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61917 (5R)-5-(azidomethyl)-3-phenyl-1,3-oxazolidin-2-one C10H10N4O2 详情 详情
(II) 61918 (5R)-3-(4-acetylphenyl)-5-(azidomethyl)-1,3-oxazolidin-2-one C12H12N4O3 详情 详情
(III) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IV) 27344 hydrazine 302-01-2 H4N2 详情 详情
(V) 61919 6-{4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-3(2H)-pyridazinone C14H12N6O3 详情 详情
(VI) 61920 6-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-3(2H)-pyridazinone C14H14N4O3 详情 详情
(VII) 61921 propyl ethanedithioate C5H10S2 详情 详情

合成路线24

该中间体在本合成路线中的序号:(III)

The reaction of 5(R)-(azidomethyl)-3-phenyloxazolidin-2-one (I) with Ac2O and MsOH gives the 4-acetylphenyl derivative (II), which is cyclized with glyoxylic acid (III) and hydrazine (IV) in hot acetic acid to yield the pyridazinone derivative (V). The reduction of the azido group of (V) by means of PPh3 in THF/water affords the aminomethyl compound (VI), which is condensed with acetic anhydride and pyridine to provide the acetamide (VII). Finally, this compound is treated with Lawesson's reagent in hot dioxane to furnish the target pyridazinethione.

1 Luehr, G.W.; Wang, S.; Hackbarth, C.J.; Gomez, M.; Trias, J.; Patel, D.V.; Gordeev, M.F.; Novel antimicrobial pyridazine phenyloxazolidinones. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61917 (5R)-5-(azidomethyl)-3-phenyl-1,3-oxazolidin-2-one C10H10N4O2 详情 详情
(II) 61918 (5R)-3-(4-acetylphenyl)-5-(azidomethyl)-1,3-oxazolidin-2-one C12H12N4O3 详情 详情
(III) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(IV) 27344 hydrazine 302-01-2 H4N2 详情 详情
(V) 61919 6-{4-[(5R)-5-(azidomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-3(2H)-pyridazinone C14H12N6O3 详情 详情
(VI) 61920 6-{4-[(5S)-5-(aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]phenyl}-3(2H)-pyridazinone C14H14N4O3 详情 详情
(VII) 61922 N-({(5S)-2-oxo-3-[4-(6-oxo-1,6-dihydro-3-pyridazinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)acetamide C16H16N4O4 详情 详情

合成路线25

该中间体在本合成路线中的序号:(II)

The cyclization of 4-(benzyloxycarbonylamino)acetophenone (I) with glyoxylic acid (II) and hydrazine (III) in hot acetic acid gives the pyridazinone (IV), which is treated first with Lawesson's reagent in hot dioxane and then with MeI and TEA in DMF to yield the methylsulfanyl pyridazine (V). The cyclization of (V) with acetamide (VI) by means of t-BuOLi in methanol/DMF affords the oxazolidinone (VII), which is finally treated with Lawesson's reagent in hot dioxane to provide the target thioacetamide.

1 Luehr, G.W.; Wang, S.; Hackbarth, C.J.; Gomez, M.; Trias, J.; Patel, D.V.; Gordeev, M.F.; Novel antimicrobial pyridazine phenyloxazolidinones. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61912 benzyl 4-acetylphenylcarbamate C16H15NO3 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 27344 hydrazine 302-01-2 H4N2 详情 详情
(IV) 61913 benzyl 4-(6-oxo-1,6-dihydro-3-pyridazinyl)phenylcarbamate C18H15N3O3 详情 详情
(V) 61914 benzyl 4-[6-(methylsulfanyl)-3-pyridazinyl]phenylcarbamate C19H17N3O2S 详情 详情
(VI) 61915 (1S)-2-(acetylamino)-1-(chloromethyl)ethyl acetate C7H12ClNO3 详情 详情
(VII) 61916 N-[((5S)-3-{4-[6-(methylsulfanyl)-3-pyridazinyl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide C17H18N4O3S 详情 详情

合成路线26

该中间体在本合成路线中的序号:(II)

The cyclization of 4-(benzyloxycarbonylamino)acetophenone (I) with glyoxylic acid (II) and hydrazine (III) in hot acetic acid gives the pyridazinone (IV), which is treated first with Lawesson's reagent in hot dioxane and then with MeI and TEA in DMF to yield the methylsulfanyl pyridazine (V). The cyclization of (V) with acetamide (VI) by means of t-BuOLi in methanol/DMF affords the oxazolidinone (VII), which is finally treated with Lawesson's reagent in hot dioxane to provide the target thioacetamide.

1 Luehr, G.W.; Wang, S.; Hackbarth, C.J.; Gomez, M.; Trias, J.; Patel, D.V.; Gordeev, M.F.; Novel antimicrobial pyridazine phenyloxazolidinones. 42nd Intersci Conf Antimicrob Agents Chemother (Sept 27 2002, San Diego) 2002, Abst F-1320.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 61912 benzyl 4-acetylphenylcarbamate C16H15NO3 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 27344 hydrazine 302-01-2 H4N2 详情 详情
(IV) 61913 benzyl 4-(6-oxo-1,6-dihydro-3-pyridazinyl)phenylcarbamate C18H15N3O3 详情 详情
(V) 61914 benzyl 4-[6-(methylsulfanyl)-3-pyridazinyl]phenylcarbamate C19H17N3O2S 详情 详情
(VI) 61915 (1S)-2-(acetylamino)-1-(chloromethyl)ethyl acetate C7H12ClNO3 详情 详情
(VII) 61916 N-[((5S)-3-{4-[6-(methylsulfanyl)-3-pyridazinyl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide C17H18N4O3S 详情 详情

合成路线27

该中间体在本合成路线中的序号:(II)

 

1 Mansour T,Jin H.et al.1997.Processes for the diastereoselective synthesisof nucleoside analogues. US 5696254
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36958 1,4-dithiane-2,5-diol 40018-26-6 C4H8O2S2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(III) 66301 (2S,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid   C4H6O4S 详情 详情
(IV) 66302 (2R,5R)-5-hydroxy-1,3-oxathiolane-2-carboxylic acid 147027-04-1 C4H6O4S 详情 详情
(V) 15620 (2R,5R)-5-(acetoxy)-1,3-oxathiolane-2-carboxylic acid 147027-05-2 C6H8O5S 详情 详情
(VI) 66303 (2R,5S)-2-isopropyl-5-methylcyclohexanol   C10H20O 详情 详情
(VII) 55067 (1R,2S,5R)-2-isopropyl-5-methylcyclohexyl (2R,5R)-5-(acetyloxy)-1,3-oxathiolane-2-carboxylate C16H26O5S 详情 详情
(VIII) 66304     C16H26O5S 详情 详情
(IX) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(X) 66305 (2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate   C18H26FN3O4S 详情 详情

合成路线28

该中间体在本合成路线中的序号:(II)

 

1 Ren D.2005.Inclustrial scale preparation of emtricitabine.发明专利申请公开说明书,CN 1563002
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 36959 5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine C10H20FN3OSi2 详情 详情
(I) 36958 1,4-dithiane-2,5-diol 40018-26-6 C4H8O2S2 详情 详情
(II) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(VI) 66303 (2R,5S)-2-isopropyl-5-methylcyclohexanol   C10H20O 详情 详情
(X) 66305 (2S,5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate   C18H26FN3O4S 详情 详情
(XI) 66306 (2R,5S)-2-isopropyl-5-methylcyclohexyl 2-oxoacetate   C12H20O3 详情 详情
(XII) 66308 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate   C14H24O4S 详情 详情
(XIII) 66307 (5R)-(1S,2R,5S)-2-isopropyl-5-methylcyclohexyl 5-hydroxy-1,3-oxathiolane-2-carboxylate   C16H26O5S 详情 详情

合成路线29

该中间体在本合成路线中的序号:(XXI)

5-Hydroxy-4-propyl-2-furanone (V) is obtained by aldol condensation of glyoxylic acid (XXI) with valeraldehyde (XXII) in the presence of morpholine in heptane, followed by cyclization of the intermediate aldehyde acid under acidic conditions .
Preparation of iodoacyl chloride (VIII) starts with the conjugate addition of propylmagnesium bromide (XXIV) to 2-furanone (XXIII) in the presence of CuI and TMSCl in ethyl ether to produce 4-propylbutyrolactone (XXV), which undergoes lactone ring opening by means of iodotrimethylsilane in CH2Cl2, affording 3-(iodomethyl)hexanoic acid (XXVI), and finally, chlorination of acid (XXVI) with SOCl2 in benzene .

1 Surtees, J., Lurquin, F., Diouf, O. (UCB SA). Process for preparing 2-oxo-1-pyrrolidine derivatives. CA 2538938, EP 1667967, JP 2007515387, US 2007100150, US 7629474, WO 2005028435.
2 Kenda, B.M., Matagne, A.C., Talaga, P.E. et al. Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. J Med Chem 2004, 47(3): 530-49.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(V) 58391 5-hydroxy-4-propyl-2(5H)-furanone;5-hydroxy-4-propyl-2-furanone 78920-10-2 C7H10O3 详情 详情
(VIII) 69031 3-(iodomethyl)hexanoyl chloride   C7H12ClIO 详情 详情
(XXI) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XXII) 13409 n-Valeraldehyde; Pentanal 110-62-3 C5H10O 详情 详情
(XXIII) 19267 2(5H)-furanone;furan-2(5H)-one;2-Buten-1,4-olide 497-23-4 C4H4O2 详情 详情
(XXIV) 10790 Bromo(propyl)magnesium;bromopropylMagnesium;4-propylbutyrolactone;propylmagnesiumbromide;n-propylmagnesium bromide;Bromopropylmagnesium; 927-77-5 C3H7BrMg 详情 详情
(XXV) 69043 4-propyldihydrofuran-2(3H)-one   C7H12O2 详情 详情
(XXVI) 69044 3-(iodomethyl)hexanoic acid   C7H13IO2 详情 详情

合成路线30

该中间体在本合成路线中的序号:(XXXIV)

Oxidation of cyclobutanemethanol (XXVIII) with NaOCl and catalytic TEMPO by means of KBr and NaHCO3 in CH2Cl2/H2O gives cyclobutanecarboxaldehyde (XXIX), which is then condensed with nitromethane in the presence of Et3N in toluene to yield the nitro alcohol (XXX). Subsequent treatment of alcohol (XXX) with acetic anhydride in the presence of DMAP furnishes a mixture of the acetate ester (XXXI) and the dehydration compound (2-nitrovinyl)cyclobutane (XXXII), which can also be obtained as the only reaction product by dehydration of nitro alcohol (XXX) with MsCl in the presence of Et3N. Reduction of the mixture of compounds (XXXI) and (XXXII) or the nitro olefin (XXXII) by catalytic hydrogenation over Pd/C in MeOH optionally in the presence of Et3N, or with NaBH4 in PEG-400/H2O or t-BuOH, affords (2-nitroethyl)cyclobutane (XXXIII), which is condensed with glyoxylic acid (XXXIV) in the presence of Et3N to yield the nitro hydroxy acid (XXXV). Then, compound (XXXV) is reduced with H2 over Pd/C in MeOH and esterified with MeOH and p-TsOH·H2O to give amino ester (XXXVI). Finally, aminolysis of methyl ester (XXXVI) with NH3 and NH4OH in MeOH followed by N-protection by means of Boc2O and K2CO3 in MeOH/H2O yields intermediate (XXVII) .

1 Park, J., Vater, E.J., Dong, S., Iwama, T., Raghavan, R.R., Lee, H.-C.,Wong, G.S.K. (Schering Corp.). Preparation of 3-amino-3-(cyclobutylmethyl)-2-(hydroxy)-propionamide hydrochloride. CA 2672570, WO 2008082486.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXVII) 69353 tert-butyl (4-amino-1-cyclobutyl-3-hydroxy-4-oxobutan-2-yl)carbamate C13H24N2O4 详情 详情
(XXVIII) 69354 cyclobutanemethanol;Cyclobutylcarbinol;Hydroxymethylcyclobutane 4415-82-1 C5H10O 详情 详情
(XXIX) 69355 cyclobutanecarbaldehyde;Cyclobutanaldehyde;Cyclobutylcarboxaldehyde;Formylcyclobutane 2987-17-9 C5H8O 详情 详情
(XXX) 69356 1-cyclobutyl-2-nitroethanol C6H11NO3 详情 详情
(XXXI) 69357 1-cyclobutyl-2-nitroethyl acetate C8H13NO4 详情 详情
(XXXII) 69358 (E)-(2-nitrovinyl)cyclobutane C6H9NO2 详情 详情
(XXXIII) 69359 (2-nitroethyl)cyclobutane C6H11NO2 详情 详情
(XXXIV) 15618 2-Oxoacetic acid; Glyoxylic Acid 298-12-4 C2H2O3 详情 详情
(XXXV) 69360 4-cyclobutyl-2-hydroxy-3-nitrobutanoic acid C8H13NO5 详情 详情
(XXXVI) 69361 methyl 3-amino-4-cyclobutyl-2-hydroxybutanoate 4-methylbenzenesulfonate C9H17NO3.C7H8O3S 详情 详情
Extended Information